- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06695793
Niche Investigated: Closure of Hysterotomy & Evaluation of 3 Suturing Techniques (Running, Interrupted, and Locked)
November 17, 2024 updated by: Abdalla Mousa, Cairo University
This study aims to explore the impact of three different suturing techniques (Running, Interrupted & Locked) that used to close the uterine incision at the cesarean section on the formation of a cesarean scar niche
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
225
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Abdalla Moussa
- Phone Number: +20127664430
- Email: Dr_abdallamousa@yahoo.com
Study Contact Backup
- Name: Sally Collins
- Phone Number: +44 7958 656885
- Email: sally.collins@wrh.ox.ac.uk
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Cairo University
-
Contact:
- Ibrahim Fawzy
- Phone Number: +201062641235
- Email: ibrahimfawzyibrahimfawzy@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Women with a singleton pregnancy scheduled for elective cesarean section
- Gestational age at the time of cesarean section between 38 and 40 weeks.
- Willingness to participate in the study and provide informed consent
- Age between 18 and 35 years old.
- BMI <30
Exclusion Criteria:
- Known uterine anomalies or previous uterine surgery (e.g, myomectomy, uterine septum resection)
- Pre-existing medical conditions contraindicating cesarean delivery or affecting uterine healing (e.g., Anemia, Diabetes)
- Current smokers.
- Non-cephalic presentation of the fetus.
- Low-lying anterior wall placenta and placenta previa.
- Inability to provide informed consent (e.g., cognitive impairment, language barrier)
- Any condition deemed by the attending physician to pose a risk to the participant or compromise the study's integrity, for example, Patients who will require excessive suturing for further hemostasis or those who require ligation of one or both uterine arteries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group (A)
Interrupted Sutures: The first layer of the uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line.
Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.
|
The first layer of uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line.
Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.
|
|
Experimental: Group (B)
Locked Sutures: The first layer of the uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling.
The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.
|
The first layer of uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling.
The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.
|
|
Experimental: Group (C)
Running Continuous Sutures: Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.
|
Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of caesarean scar niche and its dimensions.
Time Frame: 6-12 weeks post-cesarean section
|
Follow-up visits will be scheduled at 6-12 weeks post-cesarean section to assess caesarean section niche formation using trans-vaginal ultrasound using Samsung Elite with endovaginal probe of frequency 6 - 12 MHz.
Trained sonographers, blinded to the participants' suturing group, will perform the ultrasound examinations to evaluate caesarean section niche presence and its dimensions.
|
6-12 weeks post-cesarean section
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative time
Time Frame: during operation
|
during operation
|
|
Estimate blood loss
Time Frame: during operation
|
during operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
November 17, 2024
First Submitted That Met QC Criteria
November 17, 2024
First Posted (Estimated)
November 19, 2024
Study Record Updates
Last Update Posted (Estimated)
November 19, 2024
Last Update Submitted That Met QC Criteria
November 17, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- MD-308-2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caesarean Scar Niche
-
Benha UniversityCompletedCesarean Section Complications | Scarred Uterus | Scar NicheEgypt
-
Minia UniversityNot yet recruiting
-
Sohag UniversityRecruiting
-
Benha UniversityCompletedCesarean Section Complications | Myometrial Remodeling | Suture Techniques | Scar NicheEgypt
-
University of AarhusRanders Regional HospitalActive, not recruitingCesarean Scar NicheDenmark
-
International Peace Maternity and Child Health...CompletedUterine Caesarean Scar DefectChina
-
Benha UniversityCompletedCesarean Section Complications | Contraceptive Device; Complications | Myometrial Remodeling | Scar NicheEgypt
-
Zagazig UniversityRecruitingCesarean Scar NicheEgypt
-
Alexandria UniversityCompletedCS Scar Defect(Niche) How to AvoidEgypt
Clinical Trials on Interrupted Sutures
-
Aljazeera HospitalCompleted
-
St Joseph University, Beirut, LebanonGroupe Hospitalier Paris Saint JosephUnknown
-
Heidelberg UniversityUnknownHernia | LaparotomyGermany
-
Assiut UniversityNot yet recruiting
-
Postgraduate Institute of Dental Sciences RohtakCompletedPeriodontitis | Healing Surgical WoundsIndia
-
Ain Shams UniversityCompletedLoss of Keratinized Gingiva Around Dental ImplantsEgypt
-
Queen's UniversityCompletedEducation, Medical | SuturesCanada
-
Rothman Institute OrthopaedicsEthicon, Inc.CompletedOsteoarthritis, Hip
-
Shanghai 10th People's HospitalEnrolling by invitationColorectal Cancer | Rectal Neoplasms | Low Rectal CancerChina
-
University of ManitobaCompletedPhimosis | ParaphimosisCanada